Marjolein J E Greuter (Marjolein Je Greuter)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Top Venues

Cancer research communications

Therapeutic advances in medical oncology

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tara C Boute, Hidde Swartjes, Marjolein J E Greuter, Marloes A G Elferink, Rik Van Eekelen, Geraldine R Vink, Johannes H W de Wilt, Veerle M H Coupé
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study. Cancer research communications 4 (2) (2024)
Astrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, Geraldine R Vink, Jillian Phallen, Victor E Velculescu, Gerrit A Meijer, Daan van den Broek, Miriam Koopman, Jeanine M L Roodhart, Remond J A Fijneman, Valesca P Retèl, Veerle M H Coupé
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer. Therapeutic advances in medical oncology 16 (2024)
Tara C Boute, Hidde Swartjes, Marjolein J E Greuter, Marloes A G Elferink, Rik Van Eekelen, Geraldine R Vink, Johannes H W de Wilt, Veerle M H Coupé
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study. Cancer research communications 4 (2) (2024)
Tara C Boute, Hidde Swartjes, Marjolein J E Greuter, Marloes A G Elferink, Rik Van Eekelen, Geraldine R Vink, Johannes H W de Wilt, Veerle M H Coupé
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study. Cancer research communications 4 (2) (2024)
Astrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, Geraldine R Vink, Jillian Phallen, Victor E Velculescu, Gerrit A Meijer, Daan van den Broek, Miriam Koopman, Jeanine M L Roodhart, Remond J A Fijneman, Valesca P Retèl, Veerle M H Coupé
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer. Therapeutic advances in medical oncology 16 (2024)
Tara C Boute, Hidde Swartjes, Marjolein J E Greuter, Marloes A G Elferink, Rik Van Eekelen, Geraldine R Vink, Johannes H W de Wilt, Veerle M H Coupé
Cumulative incidence, risk factors and overall survival of disease recurrence after curative resection of stage II-III colorectal cancer: a population-based study. Cancer research communications (2024)
Francine van Wifferen, Lucie de Jonge, Joachim Worthington, Marjolein J E Greuter, Jie-Bin Lew, Claude Nadeau, Rosita van den Puttelaar, Eleonora Feletto, Jean H E Yong, Iris Lansdorp-Vogelaar, Karen Canfell, Veerle M H Coupé, null null
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. Journal of medical screening 29 (2) (2021)
Jie-Bin Lew, Marjolein J E Greuter, Michael Caruana, Emily He, Joachim Worthington, D James St John, Finlay A Macrae, Eleonora Feletto, Veerle M H Coupé, Karen Canfell
Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical decision making : an international journal of the Society for Medical Decision Making 40 (6) (2021)
Willemijn de Klaver, Pieter H A Wisse, Francine van Wifferen, Linda J W Bosch, Connie R Jiménez, René W M van der Hulst, Remond J A Fijneman, Ernst J Kuipers, Marjolein J E Greuter, Beatriz Carvalho, Manon C W Spaander, Evelien Dekker, Veerle M H Coupé, Meike de Wit, Gerrit A Meijer
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study. Annals of internal medicine 174 (9) (2021)
Gabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst, Felice N van Erning, Miriam Koopman, Jan P Medema, Louis Vermeulen, Jan Nicolaas Maria IJzermans, Geraldine R Vink, Cornelis J A Punt, Veerle M H Coupé
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (9) (2021)
Marjolein J E Greuter, Beatriz Carvalho, Meike de Wit, Evelien Dekker, Manon Cw Spaander, Gerrit A Meijer, Manon van Engeland, Veerle Mh Coupé
Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening? Journal of comparative effectiveness research 9 (8) (2020)
Gabrielle Jongeneel, Thomas Klausch, Felice N van Erning, Geraldine R Vink, Miriam Koopman, Cornelis J A Punt, Marjolein J E Greuter, Veerle M H Coupé
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data. International journal of cancer 146 (11) (2019)
Jie-Bin Lew, D James B St John, Finlay A Macrae, Jon David Emery, Hooi C Ee, Mark A Jenkins, Emily He, Paul Grogan, Michael Caruana, Marjolein J E Greuter, Veerle M H Coupé, Karen Canfell
Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27 (12) (2018)